The California Neuropsychiatric Institute

The California Neuropsychiatric Institute offers Spravato esketamine treatment in Manhattan Beach, California, for adults with treatment resistant depression. The intranasal spray works differently from standard antidepressants and can ease symptoms within hours when paired with an oral medication.

This is the institute's coastal office, bringing its research driven approach to the South Bay.

Care is led by CEO Dr. Hassamal, an active research investigator with extensive experience in pharmacotherapy and neuromodulation. The team uses neuropsychological, genetic, and biomarker testing to personalize each plan, and clinical trial participation is available. Appointments are scheduled individually rather than through set walk in hours. The clinic serves Manhattan Beach, Hermosa Beach, Redondo Beach, El Segundo, and Torrance.